Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2014

View Archived Issues

Combination of GPR40 agonist and GLP-1 agonist improves glucose control in type 2 diabetes

WNT-974, a porcupine inhibitor targeting Wnt signaling in clinical testing

Candidate antidepressant mGlu2 and 3 receptor antagonists identified at Lilly

Development of a mouse model mimicking human ulcerative colitis

Paradigm to conduct genomic analysis to predict response to Tesaro's TSR-011

NuSirt Biopharma initiates phase II study of metformin/leucine combinations

Cardiac-selective sodium current inhibitor discovered at Gilead Sciences

ENSPIRIT trial of custirsen passes interim futility analysis

Heptares uses StaR platform to derive orexin receptor antagonists

Antitope and University College London to generate fully humanized antibodies

AbbVie begins phase I study of ABT-957 in subjects with Alzheimer's disease

Genentech begins phase I study of MOXR-0916 in locally advanced or metastatic solid tumors

Novel anti-HCV MAbs disclosed by Genentech

Researchers in Japan disclose humanized anti-HMGB1 MAbs

FDA grants Insys Therapeutics' cannabidiol orphan drug designation for GBM

Advaxis and Merck & Co. to collaborate on cancer immunotherapy combination trial

Nuvilex's cancer treatment evaluated in preclinical studies for malignant ascites

Enrollment open in phase I study of CB-5083 for relapsed/refractory multiple myeloma

Stanford University begins first-in-human study of Hu5F9-G4 for solid tumors

Vertex patents novel Na channel modulators

Naurex designs a new series of NMDA receptor modulators

DeuteRx divulges new deuterated PPAR-gamma agonists

Latuda launched in the U.K. for schizophrenia

Phase III REGULATE-PCI of Revolixys Kit halted

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...